Radiometer: The UK Based Company Announces POCT Analyzers Help Tackle ED Overcrowding with a Faster Diagnoses

Radiometer reports that a new case study shows how point-of-care testing (POCT) involving Radiometer’s blood gas and immunoassay analyzers, has led to faster diagnoses and improved patient experience in the emergency department (ED) at Queen’s Hospital*, Romford.

The study, authored by Clare Bailey, Divisional Director of Healthcare Professionals, Cancer and Clinical Support at Barking, Havering, and Redbridge University Hospitals NHS Trust, shows how Radiometer’s POCT ABL90 FLEX PLUS blood gas analyzers and AQT90 FLEX immunoassay analyzers have enabled the ED team to manage increasing patient numbers and deliver high-quality care.

Commenting on Radiometer’s POCT analyzers, Clare Bailey said: “The benefits of the ABL90 FLEX PLUS blood gas analyzer are clear. It measures urea and blood urea nitrogen (BUN) on very small sample volumes, which helps in the stratification of patients with suspected gastrointestinal bleeding, respiratory infections, or dehydration.

Additionally, it is one of the few POCT instruments on the market that can also measure creatinine and it’s important for our department to have this capability because we can triage our patients more quickly. On top of that, we also have the AQT90 FLEX analyzer, which was a great benefit for the ED staff, because it measures, for example, troponins, D-dimer and CRP – having all three was a real game-changer for us.”

The full case study can be found at https://www.radiometer.co.uk/en-gb/knowledge-center/customer-stories/queens-hospital

*Queen’s Hospital in Romford is part of the Barking, Havering and Redbridge University Hospitals NHS Trust (BHRUT) in London, UK. Clare Bailey is the divisional director of healthcare professionals, cancer and clinical support at the BHRUT.

 

 

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.